|
16
|
99
|
5agzA |
Disubstituted bis-thf moieties as new p2 ligands in non-peptidal hiv- 1 protease inhibitors (ii) |
|
16
|
99
|
5ahcA |
Disubstituted bis-thf moieties as new p2 ligands in non-peptidal hiv- 1 protease inhibitors (ii) |
|
19
|
99
|
4ye3A |
Crystal structure of multidrug resistant hiv-1 protease clinical isolate pr20 with inhibitor grl-4410a |
|
84
|
330
|
4yckA |
Endothiapepsin in complex with fragment 211 |
|
19
|
99
|
5copA |
X-ray crystal structure of wild type hiv-1 protease in complex with grl-097 |
|
93
|
333
|
4y9wA |
Aspartic proteinase sapp2 secreted from candida parapsilosis at 0.82 a resolution. |
|
17
|
99
|
5ahaA |
Disubstituted bis-thf moieties as new p2 ligands in non-peptidal hiv- 1 protease inhibitors (ii) |
|
17
|
99
|
5cooA |
X-ray crystal structure of wild type hiv-1 protease in complex with grl-085 |
|
105
|
389
|
4ybiA |
Crystal structure of bace with amino thiazine inhibitor ly2811376 |
|
85
|
330
|
4y5cA |
Endothiapepsin in complex with fragment 267 |
|
85
|
329
|
4ya8A |
Structure of plasmepsin ii from plasmodium falciparum complexed with inhibitor pg394 |
|
84
|
330
|
4yd6A |
Endothiapepsin in complex with fragment 240 |
|
19
|
99
|
5cokA |
X-ray crystal structure of wild type hiv-1 protease in complex with grl-0476 |
|
88
|
329
|
4y6mA |
Structure of plasmepsin ii from plasmodium falciparum complexed with inhibitor pg418 |
|
18
|
99
|
5ah9A |
Disubstituted bis-thf moieties as new p2 ligands in non-peptidal hiv- 1 protease inhibitors (ii) |
|
16
|
99
|
5ah8A |
Disubstituted bis-thf moieties as new p2 ligands in non-peptidal hiv- 1 protease inhibitors (ii) |
|
91
|
387
|
5clmA |
1,4-oxazine bace1 inhibitors |
|
16
|
99
|
5ah7A |
Disubstituted bis-thf moieties as new p2 ligands in non-peptidal hiv- 1 protease inhibitors (ii) |
|
85
|
330
|
4yd3A |
Endothiapepsin in complex with fragment 224 |
|
86
|
330
|
4yd4A |
Endothiapepsin in complex with fragment 227 |
|
18
|
99
|
5conA |
X-ray crystal structure of wild type hiv-1 protease in complex with grl-015 |
|
20
|
116
|
4ydfA |
Crystal structure of compound 9 in complex with htlv-1 protease |
|
21
|
116
|
4ydgA |
Crystal structure of compound 10 in complex with htlv-1 protease |
|
83
|
330
|
4y3nA |
Endothiapepsin in complex with fragment 273 |
|
86
|
330
|
4y37A |
Endothiapepsin in complex with fragement 305 |
|
78
|
330
|
4y3yA |
Endothiapepsin in complex with fragment b42 |
|
84
|
330
|
4y5pA |
Endothiapepsin in complex with fragment 338 |
|
84
|
330
|
4y3gA |
Endothiapepsin in complex with fragment 285 |
|
84
|
330
|
4y3xA |
Endothiapepsin in complex with fragment 171 |
|
86
|
330
|
4y3tA |
Endothiapepsin in complex with fragment 207 |
|
85
|
330
|
4y4tA |
Endothiapepsin in complex with fragment 114 |
|
86
|
330
|
4y3mA |
Endothiapepsin in complex with fragment 103 |
|
86
|
330
|
4y43A |
Endothiapepsin in complex with fragment 42 |
|
85
|
330
|
4y5aA |
Endothiapepsin in complex with fragment 206 |
|
88
|
330
|
4y36A |
Endothiapepsin in complex with fragment 4 |
|
84
|
330
|
4y50A |
Endothiapepsin in complex with fragment 81 |
|
85
|
330
|
4y4uA |
Endothiapepsin in complex with fragment 14 |
|
79
|
330
|
4y4dA |
Endothiapepsin in complex with fragment b51 |
|
101
|
392
|
4xxsA |
Crystal structure of bace1 with a pyrazole-substituted tetrahydropyran thioamidine |
|
88
|
330
|
4y56A |
Endothiapepsin in complex with fragment 58 |
|
85
|
330
|
4y47A |
Endothiapepsin in complex with fragment 162 |
|
86
|
330
|
4y3aA |
Endothiapepsin in complex with fragment 181 |
|
85
|
330
|
4y3lA |
Endothiapepsin in complex with fragment 205 |
|
88
|
330
|
4y54A |
Endothiapepsin in complex with fragment 56 |
|
84
|
330
|
4y4eA |
Endothiapepsin in complex with fragment 131 |
|
82
|
330
|
4y3fA |
Endothiapepsin in complex with fragment 78 |
|
85
|
330
|
4y5bA |
Endothiapepsin in complex with fragment 261 |
|
83
|
330
|
4y3wA |
Endothiapepsin in complex with fragment 35 |
|
85
|
330
|
4y4aA |
Endothiapepsin in complex with fragment 286 |
|
84
|
330
|
4y4zA |
Endothiapepsin in complex with fragment 73 |
